Glossary

Regulatory acronyms

  • PBS – Pharmaceutical Benefits Scheme
  • TGA– Therapeutic Goods Association
  • PBAC – Pharmaceutical Benefits Advisory Committee
  • MSAC – Medical Services Advisory Committee
  • LSDP – Life Saving Drugs Program
  • ATAGI – Australian Technical Advisory Group on Immunisation
  • ESC – Economic Sub-Committee
  • DUSC – Drug Utilisation Sub-Committee
  • ARTG – Australian Register of Therapeutic Goods (ARTG)

Company acronyms

  • AZ – AstraZeneca
  • BI – Boehringer Ingelheim
  • MSD – Merck Sharp Dohme
  • BMS – Bristol Myers Squibb

Regulatory terms

  • Cost-effectiveness – A medicine is considered cost-effective if the incremental benefits it offers over its main comparator(s) justify its incremental costs and harms.
  • Cost-minimisation – An economic evaluation that evaluates the proposed medicine against the least costly comparator once it has been found no worse than its main comparator(s) in terms of effectiveness and toxicity.

News Just In

No recent news posted!